Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.
ALXNShowing 0 of 12 quarters
Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Adage Capital Partners GP held 5,238,014 shares of ALXN (Alexion Pharmaceuticals), worth $962.3M. Adage Capital Partners GP's 13F filings listed ALXN from Q4 2018 to Q2 2021, 11 quarterly filings. ALXN was 1.9% of Adage Capital Partners GP's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, STATE STREET CORP